← Back
$BBIO All transactions

BridgeBio Pharma, Inc.

▼ SELL 10b5-1 Plan

$ Value

$2.4M

Shares

50,000

Price

$48

Filed

Aug 12

Insider

Name

HOMCY CHARLES J

Title

CIK

0001192591

Roles

Director

Transaction Details

Transaction Date

2025-08-11

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

916,674

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 8, 2025. | Represents the weighted average sale price of the shares sold from $45.395 to $46.38 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | Represents the weighted average sale price of the shares sold from $46.40 to $46.84 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Filing Info

Accession No.

0000950170-25-107510

Form Type

4

Issuer CIK

0001743881

HOMCY CHARLES J's History

Date Ticker Type Value
2025-10-23 MAZE G $0
2025-09-22 MAZE A $0
2025-08-11 BBIO $2.4M
2025-08-08 BBIO $8.8M
2025-08-08 BBIO $2.7M
2025-06-27 BBIO G $0
2025-06-20 BBIO A $0
2025-06-20 BBIO A $0

Other Insiders at BBIO (90d)

Insider Bought Sold Last
Kumar Neil
Chief Executive Officer
$6.0M 2026-04-10